A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2006
10/11/2006	CN1279054C Type I cytokine receptor TCCR
10/11/2006	CN1279053C Modulators for beta-amyloid peptide aggregation comprising D-amino acids
10/11/2006	CN1279051C DNA sequence and encoded mammary-specific breast cancer protein
10/11/2006	CN1278737C Compound medicinal formulation with bioactivity
10/11/2006	CN1278736C Novel dopaminergic neuron protective factor, and its application
10/11/2006	CN1278735C Crystallographic form of a cyclic depsipeptide having improved activity
10/11/2006	CN1278683C Use of dipeptidyl peptidase IV inhibitor in preparing medicine for treating anxiety neurosis
10/10/2006	US7119248 Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof
10/10/2006	US7119190 Therapy
10/10/2006	US7119186 Nucleotide sequences coding polypeptide for use in the treatment of spinocerebellar ataxia
10/10/2006	US7119185 nucleotide sequences that code serine/threonine protein kinase, used for analyzing or screening breast cancers; gene therapy
10/10/2006	US7119183 Rapid immunoselection cloning method
10/10/2006	US7119176 Antibodies specific to human prostacyclin synthase
10/10/2006	US7119170 Administering a polypeptide; blood disorders
10/10/2006	US7119169 Comprises p65 binding polypeptide (RAI) for diagnosis and treatment of adult respiratory distress syndrome, asthma, allograft rejection, cancer and inflammatory/autoimmune/vasoreconstrictive diseases
10/10/2006	US7119168 Paralytic peptide for use in neuromuscular therapy
10/10/2006	US7119166 Universal procedure for refolding recombinant proteins
10/10/2006	US7119165 Nogo receptor-mediated blockade of axonal growth
10/10/2006	US7119124 Pharmaceutical compositions containing plasma protein
10/10/2006	US7119085 Inhibit amyloid protein deposits
10/10/2006	US7119080 Boronic ester and acid compounds, synthesis and uses
10/10/2006	US7119073 Peptides and their use as inhibitors of hepatitis C virus ns3 protease
10/10/2006	US7119072 Macrocyclic peptides active against the hepatitis C virus
10/10/2006	US7119071 Amino terminal substance P compositions and methods for using the same
10/10/2006	US7119070 Antimicrobial theta defensins, analogs thereof, and methods of use
10/10/2006	US7119069 Human kininogen D3 domain polypeptide as an anti-angiogenic and anti-tumor agent
10/10/2006	US7119066 Replacing cysteine 17 with alanine, glutamine 63 with arginine and a deletion of the terminal 15 amino acid residues; treatment of huntington's disease, obesity, and gestational or adult onset diabetes
10/10/2006	US7119065 Metal complex-protein composite and oxidation catalyst
10/10/2006	US7119064 Oxidation resistance; controlling lipid peroxidation
10/10/2006	US7119063 Alzheimer's disease therapy; polypeptides
10/10/2006	US7119062 Analgesics for treatment of surgical incisions with collagen
10/10/2006	US7119061 Dalbavancin compositions for treatment of bacterial infections
10/10/2006	US7118915 Subjecting apoliprotein to mutagenesis at sequence positions 34 to 38 and other positions and muteins of aliproteins
10/10/2006	US7118905 Nucleic acid encoding angiogenesis inhibitor
10/10/2006	US7118903 Comprises genetically engineered protein for use in treatment and prevention of cancer, obesity, cardiac, vascular, neurologic and or aging disorders
10/10/2006	US7118890 Antibodies to vertebrate delta proteins and fragments
10/10/2006	US7118885 Nucleic acid encoding vitamin D receptor related polypeptide
10/10/2006	US7118879 Obtaining a gene encoding a potential binding domain by random mutagenesis of a few predetermined codons, fusing it to a genetic element, causing the resulting chimeric expression product to be displayed on the outer surface of a cell/virus
10/10/2006	US7118877 Identifying enzyme modulators for treating neurodegenerative, autoimmune and tumor diseases
10/10/2006	US7118873 Polynucleotides encoding cellular transporters and methods of use thereof
10/10/2006	US7118872 Used in detection, isolation, and/or purification
10/10/2006	US7118859 Methods for inhibiting HIV-1 infection
10/10/2006	US7118856 Enzyme catalyst; polypeptides; crystal structure
10/10/2006	US7118853 Providing tumor sample; Detecting expression or activity of a gene encoding the polypeptide in tumor sample; classifying the tumor as belonging to a tumor subclass
10/10/2006	US7118756 Recombinant protective protein from Streptococcus pneumoniae
10/10/2006	US7118753 Enhancing cell-based immunotherapy
10/10/2006	US7118752 Administering to one or more malignant cells an effective amount of a peptide species comprising an E-domain of insulin-like growth factor I (IGF-I)
10/10/2006	US7118750 Modified TNF-alpha molecules, DNA encoding such and vaccines comprising such modified TNF-alpha and DNA
10/10/2006	US7118748 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
10/10/2006	US7118747 AT4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents
10/10/2006	US7118746 Conditioned cell culture medium compositions and methods of use
10/10/2006	US7118743 Bispecific molecules cross-linking ITIM and ITAM for therapy
10/10/2006	US7118742 Ligand for herpes simplex virus entry mediator and methods of use
10/10/2006	US7118741 synthetic bi-functional or cross-linker protein which is capable of binding to a molecular species, particularly a macromolecule such as an antibody; having a binding region capable of binding the to transcytosis receptors present in epithelial cells (such a mucosal cells)
10/10/2006	US7118737 Adjust pharmokinetics; ligation, binding, overlapping; nonimmunogenic; genetic engineering
10/10/2006	CA2336682C Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof
10/10/2006	CA2291233C Compositions containing bergamottin for increasing the oral bioavailability of pharmaceutical agents
10/10/2006	CA2274307C Hypersensitive response induced resistance in plants by seed treatment
10/10/2006	CA2262778C Conformationally constrained backbone cyclized somatostatin analogs
10/10/2006	CA2238277C Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
10/10/2006	CA2231292C Method for decreasing ldl-cholesterol concentration and increasing hdl-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease
10/10/2006	CA2212887C Monoclonal antibody specific for .beta.a4 peptide
10/10/2006	CA2189254C Modulated release from biocompatible polymers
10/10/2006	CA2175703C Alteration of sequence of a target molecule
10/05/2006	WO2006105511A1 Monitoring and modulating hgf/hgfr activity
10/05/2006	WO2006105490A2 Compositions and methods for treating diseases associated with phlpp
10/05/2006	WO2006105448A2 Proliferation of muc1 expressing cells
10/05/2006	WO2006105374A2 Optimizing pharmacodynamics of therapeutic agents for treating vascular tissue
10/05/2006	WO2006105359A2 Methods for stimulating hair growth by administering bmps
10/05/2006	WO2006105317A2 Antitumorigemic drug combination comprising a vegf-inhibitor and a thrombospondin-1 peptidomimetic
10/05/2006	WO2006105219A2 T cell therapy for the treatment of cachexia and chronic diseases
10/05/2006	WO2006105155A2 Administration of glutathione (reduced) via intravenous or encapsulated in liposome for treatment of tnf-alpha effects and elu-like viral symptoms
10/05/2006	WO2006104983A1 Therapeutic methods for type i diabetes
10/05/2006	WO2006104964A2 Inhibition of wet type age related macular degeneration (amd) by adiponectin or acrp 30
10/05/2006	WO2006104852A2 Vegf antagonist formulations
10/05/2006	WO2006104672A1 Enhancing myc-dependent sensitivity of cancer to dr5 agonists
10/05/2006	WO2006104536A2 Polynucleotides encoding stem cell factor-like proteins
10/05/2006	WO2006104424A1 Method for obtaining protein growth factors, a growth factor and fibroblast proliferation inhibitor
10/05/2006	WO2006104398A1 Copper antagonist compositions
10/05/2006	WO2006104190A1 Par-2 agonist
10/05/2006	WO2006104031A1 Method of detecting mycoplasma
10/05/2006	WO2006103494A2 Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith
10/05/2006	WO2006103455A2 Use of calcitonin as combined treatment therapy for the management of inflammatory disease conditions
10/05/2006	WO2006103429A2 High affinity hiv t cell receptors
10/05/2006	WO2006103352A1 Use of compounds inducing synthesis of sirt proteins in or for preparing a cosmetic or pharmaceutical compositions
10/05/2006	WO2006103274A1 Age inhibitors
10/05/2006	WO2006103206A2 Combinations comprising at least one direct thrombin inhibitor for the treatment of thrombosis
10/05/2006	WO2006103015A1 Antibacterial amide-macrocycles v
10/05/2006	WO2006102854A1 A conjugate of biomacromolecule with bioreductive and preparative method thereof
10/05/2006	WO2006102728A2 Inclusion compounds of dioclein, floranol or analogs with cyclodextrin and their use for treating cardiovascular diseases
10/05/2006	WO2006102720A1 Isolation of inhibitor of ires-mediated translation
10/05/2006	WO2006102715A1 Methods and agents for modulating cellular activity
10/05/2006	WO2006083906A3 Compositions containing the anti-angiogenic phscn-peptide
10/05/2006	WO2006081553A3 ANTI-MUC1 α/ß ANTIBODIES
10/05/2006	WO2006069240B1 Composition and treatment methods for coronary artery disease
10/05/2006	WO2006054000A3 Mutated netrin-4, fragments thereof and their use as medicines
10/05/2006	WO2006042282A3 Peptide inhibitors against seprase
10/05/2006	WO2006042151A3 Analogs of shk toxin and their uses in selective inhibition of kv1.3 potassium channels
10/05/2006	WO2006042017A3 Treatment of pulmonary hypertension using an agent that inhibits a tissue factor pathway
10/05/2006	WO2006029036A3 Combination therapy with glatiramer acetate and n-acetylcysteine for the treatment of multiple sclerosis

1 ... 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 ... 3163